TickerFacts.

Nu-Med Plus, Inc. (NUMD): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2013-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$66.2K
Year ended 2013-12-31
2012-12-31: $22.1K2013-12-31: $66.2K$66.2K
2012-12-31 R&D Expense (USD) 2013-12-31
Period endedR&D ExpenseChange YoYSource filing
2013-12-31$66.2K+199.2%2014-02-21, From 2013-01-01
2012-12-31$22.1Kn/a2014-02-21, From 2012-01-01